AgingResearch.NewsJoin free

GRGDSP

GRGDSP has been studied in 1 paper since 2024: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Jun 1, 2024: “Fibronectin/α5 Integrin Contribute to Hypertension-Associated Arterial Ageing and Calcification through Affecting BMP2/MGP Imbalance and Enhancing Vascular Smooth Muscle Cell Phenotypic Transformation”.

Intervention

1 paper studies it1 findingUpdated

PubChem

More peptides

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Animals1

What did studies of GRGDSP find?

1

Studies of GRGDSP measured 1 outcome; the most studied are vascular calcification (1 study).

Vascular calcification

downin animals1

1 study

  1. GRGDSP decreases vascular calcification.

    “Integrin receptor inhibitor of GRGDSP would delay this arterial ageing and calcification process.”

    Animalsduring ageing in SHR

    Fibronectin/α5 Integrin Contribute to Hypertension-Associated Arterial Ageing and Calcification through Affecting BMP2/MGP Imbalance and Enhancing Vascular Smooth Muscle Cell Phenotypic Transformation

    Gerontology

Latest

Related